Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $9.35 and last traded at $9.32, with a volume of 1614602 shares. The stock had previously closed at $8.82.
Wall Street Analysts Forecast Growth
A number of equities analysts have commented on AVAH shares. Raymond James Financial raised shares of Aveanna Healthcare from a "market perform" rating to an "outperform" rating and set a $9.00 price objective for the company in a research report on Monday, August 11th. UBS Group boosted their price target on Aveanna Healthcare from $8.00 to $9.00 and gave the stock a "neutral" rating in a report on Monday. Barclays raised Aveanna Healthcare from an "equal weight" rating to an "overweight" rating and upped their target price for the stock from $5.50 to $9.50 in a research report on Tuesday, August 19th. JPMorgan Chase & Co. raised Aveanna Healthcare from an "underweight" rating to a "neutral" rating and increased their price target for the company from $6.00 to $10.00 in a research report on Thursday, September 18th. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Aveanna Healthcare in a report on Wednesday, October 8th. Three analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat.com, Aveanna Healthcare currently has a consensus rating of "Hold" and a consensus target price of $8.08.
Read Our Latest Stock Analysis on Aveanna Healthcare
Aveanna Healthcare Price Performance
The company has a market cap of $1.95 billion, a PE ratio of 116.50 and a beta of 2.05. The business has a 50-day moving average of $7.96 and a 200 day moving average of $5.90.
Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last released its earnings results on Monday, May 22nd. The company reported $0.04 earnings per share (EPS) for the quarter. The firm had revenue of $450.53 million during the quarter. Aveanna Healthcare had a negative return on equity of 54.56% and a net margin of 0.85%. On average, equities analysts predict that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current fiscal year.
Hedge Funds Weigh In On Aveanna Healthcare
Institutional investors and hedge funds have recently modified their holdings of the stock. Banque Transatlantique SA purchased a new stake in Aveanna Healthcare during the 1st quarter worth approximately $25,000. Quantbot Technologies LP acquired a new position in Aveanna Healthcare during the second quarter worth $43,000. Diversified Trust Co acquired a new position in Aveanna Healthcare during the second quarter worth $57,000. Jump Financial LLC acquired a new position in Aveanna Healthcare during the first quarter worth $59,000. Finally, MQS Management LLC acquired a new position in Aveanna Healthcare during the second quarter worth $59,000. Institutional investors and hedge funds own 87.96% of the company's stock.
About Aveanna Healthcare
(
Get Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
